“Your legacy is planting seeds that you will never see flower.
Your legacy is knowing that you’ve done better for the next generation. Your legacy is having the rebellious hope that the actions you take today will create a better society tomorrow”
Dame Deborah James
The Bowelbabe Laboratory at
The Francis Crick Institute
In October 2024, we announced a £1.6m commitment towards cutting-edge science at the Francis Crick Institute.
This £1.6m donation will see researchers in The Bowelbabe Laboratory led by Professor Vivian Li, study lab-made ‘mini-bowels’ to aid the development of new, more targeted treatments for bowel cancer.
_jfif.jpg)
Cancer Grand Challenges -
Team PROSPECT
In March 2024, we committed £5 million, over five years, to uncover the reasons behind the global rise in early-on set bowel cancer. This is a cancer type that’s on the rise but it’s not well understood, and we don’t know for sure what’s causing it.
Royal Marsden - GI Consultant & Clinical Fellow
In April 2024 we committed to fund the appointment of a new GI Consultant and Clinical Fellow to join Professor David Cunningham's Team at the Royal Marsden Cancer Hospital. They will lead early phase clinical trials and focus on personalised medicines including cancer vaccines.
Cancer Grand Challenges - Team OPTIMISTICC
In April 2023 we made a £1m investment to the OPTIMISTICC Cancer Grand Challenges team who are analysing the microbiome – the trillions of bacteria, viruses and fungi residing in our bodies to find out how these microbes can drive cancer & influence a person’s response to treatment.
Cancer Research UK
Test, Evidence and Transition
We're supporting Cancer Research UK’s pioneering ‘Test Evidence Transition’ (TET) programme, which aims to improve bowel cancer diagnosis for everyone across the UK and ultimately, save more lives.
The Fund will be providing support for the two-year programme.
_JPG.jpg)
